There is some heartening news for those suffering from the 'age-related disorder' Parkinson’s disease (PD), a neurological condition which is caused by the loss of neurons that control body movements.
Lithium, an anti-depressant pill commonly prescribed to treat mood swings, bipolar disorder, and depression may be a new pharmaceutical weapon that could reduce the risk of Parkinson’s disease, finds a new study.
Severe symptoms of PD, an often disabling condition, can be eased by lithium, results of an animal study show.
